Interaction ID
ncRI-40661437
Interaction Molecules
hsa-miR-629-3p -- PCBD1
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
miRanda with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T;HEK293S
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000166228
Description
Involved in tetrahydrobiopterin biosynthesis. Seems to both prevent the formation of 7-pterins and accelerate the formation of quinonoid-BH2. Coactivator for HNF1A-dependent transcription. Regulates the dimerization of homeodomain protein HNF1A and enhances its transcriptional activity.
Pubmed ID | 23824327 | Journal | Genes & development |
---|---|---|---|
Title | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. | ||
Author | Karginov FV, Hannon GJ |
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-629-3p | acromegaly | MNDR Database |
hsa-miR-629-3p | acute myeloid leukemia | MNDR Database |
hsa-miR-629-3p | Alzheimer's disease | MNDR Database |
hsa-miR-629-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-629-3p | arthritis | MNDR Database |
hsa-miR-629-3p | asthma | MNDR Database |
hsa-miR-629-3p | autosomal recessive disease | MNDR Database |
hsa-miR-629-3p | Barrett's adenocarcinoma | MNDR Database |
hsa-miR-629-3p | B-cell lymphoma | MNDR Database |
hsa-miR-629-3p | biliary tract cancer | MNDR Database |
hsa-miR-629-3p | bladder urothelial carcinoma | MNDR Database |
hsa-miR-629-3p | bone disease | MNDR Database |
hsa-miR-629-3p | brain disease | MNDR Database |
hsa-miR-629-3p | brain stem cancer | MNDR Database |
hsa-miR-629-3p | breast cancer | MNDR Database |
hsa-miR-629-3p | Breast Neoplasms | MNDR Database |
hsa-miR-629-3p | cancer | MNDR Database |
hsa-miR-629-3p | carcinoma | MNDR Database |
hsa-miR-629-3p | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-629-3p | Carcinoma, Renal Cell | MNDR Database |
hsa-miR-629-3p | cervical squamous cell carcinoma | MNDR Database |
hsa-miR-629-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-629-3p | Chronic Pain | MNDR Database |
hsa-miR-629-3p | colon adenocarcinoma | MNDR Database |
hsa-miR-629-3p | colon cancer | MNDR Database |
hsa-miR-629-3p | colorectal cancer | MNDR Database |
hsa-miR-629-3p | diabetes mellitus | MNDR Database |
hsa-miR-629-3p | Down syndrome | MNDR Database |
hsa-miR-629-3p | esophageal carcinoma | MNDR Database |
hsa-miR-629-3p | eye disease | MNDR Database |
hsa-miR-629-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-629-3p | Glioblastoma | MNDR Database |
hsa-miR-629-3p | Growth Hormone-Secreting Pituitary Adenoma | MNDR Database |
hsa-miR-629-3p | head and neck squamous cell carcinoma | MNDR Database |
hsa-miR-629-3p | heart disease | MNDR Database |
hsa-miR-629-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-629-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-629-3p | Hodgkin's lymphoma | MNDR Database |
hsa-miR-629-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-629-3p | hypertension | MNDR Database |
hsa-miR-629-3p | inflammatory bowel disease | MNDR Database |
hsa-miR-629-3p | intellectual disability | MNDR Database |
hsa-miR-629-3p | kidney disease | MNDR Database |
hsa-miR-629-3p | large cell neuroendocrine cancer | MNDR Database |
hsa-miR-629-3p | leukemia | MNDR Database |
hsa-miR-629-3p | Liver Neoplasms | MNDR Database |
hsa-miR-629-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-629-3p | lung cancer | MNDR Database |
hsa-miR-629-3p | lung disease | MNDR Database |
hsa-miR-629-3p | lung small cell carcinoma | MNDR Database |
hsa-miR-629-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-629-3p | Lupus Vulgaris | MNDR Database |
hsa-miR-629-3p | lymphoma | MNDR Database |
hsa-miR-629-3p | malignant glioma | MNDR Database |
hsa-miR-629-3p | malignant pleural mesothelioma | MNDR Database |
hsa-miR-629-3p | melanoma | MNDR Database |
hsa-miR-629-3p | Multiple Sclerosis, Chronic Progressive | MNDR Database |
hsa-miR-629-3p | Myasthenia Gravis, Autoimmune, Experimental | MNDR Database |
hsa-miR-629-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-629-3p | nephroblastoma | MNDR Database |
hsa-miR-629-3p | neurodegenerative disease | MNDR Database |
hsa-miR-629-3p | osteosarcoma | MNDR Database |
hsa-miR-629-3p | ovarian carcinoma | MNDR Database |
hsa-miR-629-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-629-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-629-3p | pancreatic cancer | MNDR Database |
hsa-miR-629-3p | pancreatic ductal adenocarcinoma | MNDR Database |
hsa-miR-629-3p | papillary renal cell carcinoma | MNDR Database |
hsa-miR-629-3p | pituitary adenoma | MNDR Database |
hsa-miR-629-3p | Precursor Cell Lymphoblastic Leukemia-Lymphoma | MNDR Database |
hsa-miR-629-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-629-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-629-3p | progressive multifocal leukoencephalopathy | MNDR Database |
hsa-miR-629-3p | prostate adenocarcinoma | MNDR Database |
hsa-miR-629-3p | Prostatic Neoplasms | MNDR Database |
hsa-miR-629-3p | rectum adenocarcinoma | MNDR Database |
hsa-miR-629-3p | relapsing-remitting multiple sclerosis | MNDR Database |
hsa-miR-629-3p | renal cell carcinoma | MNDR Database |
hsa-miR-629-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-629-3p | retinal degeneration | MNDR Database |
hsa-miR-629-3p | skin disease | MNDR Database |
hsa-miR-629-3p | skin melanoma | MNDR Database |
hsa-miR-629-3p | small intestine cancer | MNDR Database |
hsa-miR-629-3p | stomach cancer | MNDR Database |
hsa-miR-629-3p | Stroke, Lacunar | MNDR Database |
hsa-miR-629-3p | Subarachnoid Hemorrhage, Traumatic | MNDR Database |
hsa-miR-629-3p | testicular cancer | MNDR Database |
hsa-miR-629-3p | testicular germ cell cancer | MNDR Database |
hsa-miR-629-3p | thyroid cancer | MNDR Database |
hsa-miR-629-3p | thyroid carcinoma | MNDR Database |
hsa-miR-629-3p | triple-receptor negative breast cancer | MNDR Database |
hsa-miR-629-3p | ulcerative colitis | MNDR Database |
hsa-miR-629-3p | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-629-3p | vascular disease | MNDR Database |
hsa-miR-629-3p | hyperphenylalaninemia, bh4-deficient, d | eDGAR Database |